Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

Peptide Database

265 therapeutic peptides with research summaries, clinical findings, and regulatory status.

Showing 1–28 of 28 in HormoneClear filters
HormoneIn Clinical Trials

CJC-1295

A synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that binds to albumin, extending its half-life from…

Subcutaneous injection
HormoneIn Clinical Trials

Ipamorelin

A highly selective growth hormone secretagogue that acts on ghrelin/GHS receptors in the pituitary gland to stimulate GH release. Unlike other GH…

Subcutaneous injection
HormoneFDA Approved

Sermorelin

A synthetic 29-amino acid analog of GHRH representing the shortest fully functional fragment of the native 44-amino acid hormone. Sermorelin…

Subcutaneous injection
HormoneFDA Approved

Tesamorelin (Egrifta)

A synthetic GHRH analog consisting of the 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid modification at the N-terminus to improve…

Subcutaneous injection (daily)
HormoneFDA Approved

PT-141 (Bremelanotide / Vyleesi)

A synthetic cyclic heptapeptide melanocortin receptor agonist that activates MC3R and MC4R in the central nervous system. Unlike PDE5 inhibitors that…

Subcutaneous injection (as needed)
HormoneIn Clinical Trials

Kisspeptin

A neuropeptide encoded by the KISS1 gene that serves as the master upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin…

Intravenous, Subcutaneous injection
HormoneFDA Approved

Oxytocin

A nine-amino acid cyclic neuropeptide produced in the hypothalamus and released from the posterior pituitary. Oxytocin mediates uterine contractions…

Intravenous, Intramuscular injection, Intranasal
HormoneInvestigational

GHRP-2

A synthetic hexapeptide growth hormone secretagogue that acts on the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary to stimulate growth…

Subcutaneous injection, Intravenous
HormoneInvestigational

GHRP-6

A synthetic hexapeptide growth hormone secretagogue that stimulates the anterior pituitary via GHS-R1a receptor activation. GHRP-6 produces…

Subcutaneous injection, Intravenous
HormoneInvestigational

Hexarelin

A synthetic hexapeptide growth hormone secretagogue with the highest GH-releasing potency among GHRPs. Hexarelin binds both GHS-R1a and CD36…

Subcutaneous injection, Intravenous
HormoneIn Clinical Trials

MK-677 (Ibutamoren)

An orally bioavailable, non-peptide growth hormone secretagogue that mimics the action of ghrelin at the GHS-R1a receptor. MK-677 stimulates…

Oral
HormoneFDA Approved

Macimorelin (Macrilen)

An orally bioavailable growth hormone secretagogue approved as a diagnostic agent for adult growth hormone deficiency (AGHD). Macimorelin stimulates…

Oral
HormoneFDA Approved

Cosyntropin (Cortrosyn)

A synthetic peptide consisting of the first 24 amino acids of the 39-amino acid adrenocorticotropic hormone (ACTH). Cosyntropin retains full…

Intravenous, Intramuscular injection
HormoneFDA Approved

Gonadorelin (GnRH)

A synthetic decapeptide identical to endogenous gonadotropin-releasing hormone. Gonadorelin stimulates the release of luteinizing hormone (LH) and…

Intravenous, Subcutaneous injection
HormoneFDA Approved

Capromorelin (Entyce)

Capromorelin is a selective ghrelin receptor agonist, or growth hormone secretagogue, that mimics the endogenous peptide hormone ghrelin by binding…

Oral
HormoneInvestigational

Anamorelin (Adlumiz)

Anamorelin is an orally active selective ghrelin receptor agonist designed to stimulate appetite and promote anabolic processes by mimicking…

Oral
HormoneInvestigational

Relamorelin

Relamorelin is a synthetic pentapeptide ghrelin receptor agonist designed to stimulate growth hormone secretion and promote gastric motility. It…

Subcutaneous injection
HormoneResearch Phase

Mod GRF 1-29 (CJC-1295 no DAC)

Modified GRF 1-29 is a synthetic analogue of growth hormone releasing hormone (GHRH) comprising 29 amino acids with four amino acid substitutions to…

Subcutaneous injection
HormoneInvestigational

Tabimorelin

Tabimorelin is an orally active synthetic ghrelin mimetic and selective GHS-R1a agonist developed to stimulate growth hormone release. Unlike peptide…

Oral
HormoneFDA Approved

Somatropin (Genotropin)

Somatropin is recombinant human growth hormone (rhGH) consisting of 191 amino acids identical in sequence to endogenous pituitary growth hormone. It…

Subcutaneous injection
HormoneFDA Approved

Somapacitan (Sogroya)

Somapacitan is a long-acting growth hormone analogue engineered by attaching an albumin-binding moiety to recombinant human growth hormone. This…

Subcutaneous injection
HormoneFDA Approved

Lonapegsomatropin (Skytrofa)

Lonapegsomatropin is a long-acting prodrug of somatropin created through site-specific PEGylation that releases active growth hormone after…

Subcutaneous injection
HormoneFDA Approved

Pegvisomant (Somavert)

Pegvisomant is a PEGylated growth hormone receptor antagonist engineered from human growth hormone with nine amino acid substitutions that confer…

Subcutaneous injection
HormoneFDA Approved

Mecasermin (Increlex)

Mecasermin is recombinant human insulin-like growth factor 1 (IGF-1) consisting of 70 amino acids identical to the endogenous peptide hormone. It…

Subcutaneous injection
HormoneInvestigational

GHRH (Sermorelin 1-44)

Sermorelin is a synthetic 44-amino acid peptide corresponding to the biologically active portion of human growth hormone releasing hormone (GHRH). It…

Subcutaneous injection
HormoneResearch Phase

Ghrelin (Native)

Ghrelin is a naturally occurring 28-amino acid peptide hormone produced primarily in the stomach with an essential octanoyl modification at serine-3…

Intravenous
HormoneResearch Phase

Obestatin

Obestatin is a 23-amino acid peptide hormone derived from post-translational processing of the ghrelin gene product preproghrelin. It was initially…

Subcutaneous injection, Intravenous
HormoneResearch Phase

GHRP-1

Growth Hormone Releasing Peptide-1 is a synthetic hexapeptide belonging to the growth hormone secretagogue family. It acts as a weak agonist at the…

Subcutaneous injection, Intravenous

All 265 peptides

Complete index, every profile, one click away.

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association reviews licensure but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. HIPAA-compliant infrastructure. The Peptide Association is not a medical practice.